Cambridge Epigenetix (CEGX), a UK-based life sciences company, has announced the recent completion of a $5.5M Series A financing round led by New Science Ventures and the appointment of Dr Fedja Bobanovic as CEO. Joining the financing round were founding investors Syncona Partners and Cambridge Enterprise.
The $3.8 billion the US put into the international effort to sequence the first human genome has delivered $796 billion back to the economy and created 310,000 jobs, says a new study
A national centre for sequencing plant, animal and microbial genomes is to be set up by the UK’s Biotechnology and Biological Sciences Research Council.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.